Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
32
CBZ Quote, Financials, Valuation and Earnings
Last price:
$31.22
Seasonality move
:
6.55%
Day range:
$33.39 - $35.10
52-week range:
$33.39 - $90.13
Dividend yield:
0%
P/E ratio:
22.37x
P/S ratio:
0.79x
P/B ratio:
0.99x
Volume:
1.2M
Avg. volume:
887.6K
1-year change:
-61.42%
Market cap:
$1.8B
Revenue:
$1.8B
EPS (TTM):
$1.52
Analysts' Opinion
-
Consensus RatingCBIZ, Inc. has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 1 Buy rating, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $67.50, CBIZ, Inc. has an estimated upside of 98.65% from its current price of $33.98.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $60.00 representing 100% downside risk from its current price of $33.98.
Fair Value
-
According to the consensus of 2 analysts, CBIZ, Inc. has 98.65% upside to fair value with a price target of $67.50 per share.
CBZ vs. S&P 500
-
Over the past 5 trading days, CBIZ, Inc. has underperformed the S&P 500 by -10.04% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
CBIZ, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
CBIZ, Inc. has grown year-over-year revenues for 20 quarters straight. In the most recent quarter CBIZ, Inc. reported revenues of $693.8M.
Earnings Growth
-
CBIZ, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter CBIZ, Inc. reported earnings per share of $0.48.
Enterprise value:
3.7B
EV / Invested capital:
--
Price / LTM sales:
0.79x
EV / EBIT:
12.12x
EV / Revenue:
1.40x
PEG ratio (5yr expected):
11.95x
EV / Free cash flow:
43.48x
Price / Operating cash flow:
24.65x
Enterprise value / EBITDA:
9.30x
Gross Profit (TTM):
$391.6M
Return On Assets:
2.55%
Net Income Margin (TTM):
3.89%
Return On Equity:
6.21%
Return On Invested Capital:
3.13%
Operating Margin:
12.61%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.6B | $1.7B | $2.7B | $438.9M | $693.8M | |
| Gross Profit | $230.2M | $232.4M | $391.6M | $73.5M | $113.3M | |
| Operating Income | $173.2M | $163.2M | $308.8M | $58M | $87.5M | |
| EBITDA | $208.3M | $201.1M | $402.6M | $67.6M | $111.9M | |
| Diluted EPS | $2.42 | $2.36 | $1.52 | $0.70 | $0.48 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $535.1M | $583.1M | $665.9M | $675.8M | $1B | |
| Total Assets | $1.7B | $1.9B | $2.1B | $2.1B | $4.5B | |
| Current Liabilities | $441.8M | $458.6M | $474.4M | $452.9M | $641.8M | |
| Total Liabilities | $992.1M | $1.1B | $1.3B | $1.2B | $2.7B | |
| Total Equity | $720.6M | $774.1M | $810.6M | $927.9M | $1.9B | |
| Total Debt | $334.9M | $450.8M | $574.8M | $525.9M | $1.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $123.3M | $164.4M | $104.4M | $43.7M | $24M | |
| Cash From Investing | -$80.2M | -$27.7M | -$1.1B | $8.3M | -$4.6M | |
| Cash From Financing | -$41.8M | -$143.9M | $1B | -$73.3M | -$42M | |
| Free Cash Flow | $101.7M | $150.8M | $86.1M | $41.1M | $22.1M | |
CBZ
Sector
Market Cap
$1.8B
$499.8M
Price % of 52-Week High
37.7%
84.36%
Dividend Yield
0%
0%
Shareholder Yield
-5.04%
1.6%
1-Year Price Total Return
-61.42%
--
Beta (5-Year)
0.918
0.542
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$37.40
200-day SMA
Sell
Level
$59.55
Bollinger Bands (100)
Sell
Level
45.23 - 55.85
Chaikin Money Flow
Buy
Level
107.6M
20-day SMA
Sell
Level
$41.83
Relative Strength Index (RSI14)
Sell
Level
23.98
ADX Line
Sell
Level
41.39
Williams %R
Buy
Level
-95.152
50-day SMA
Sell
Level
$48.10
MACD (12, 26)
Sell
Level
-3.99
25-day Aroon Oscillator
Sell
Level
-84
On Balance Volume
Neutral
Level
114.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.6369)
Sell
CA Score
(Annual)
Level (-0.6371)
Sell
Beneish M-Score
(Annual)
Level (-2.0245)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (1.6883)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
CBIZ, Inc. is a professional services advisor to middle market businesses and organizations nationwide. It offers its services in accounting, tax, advisory, benefits, insurance, and technology. The firm delivers forward-thinking insights and actionable solutions to help clients anticipate what's next and discover new ways to accelerate growth. It operates through the following segments: Financial Services, Benefits and Insurance Services and National Practices. The Financial Services segment offers accounting, tax, government health care consulting, financial advisory, valuation, and risk advisory services. The Benefits and Insurance Services segment includes group health benefits consulting, property and casualty brokerage, retirement plan services, and payroll. The National Practices segment deals with managed networking and hardware, and healthcare consulting. The company was founded by Michael G. DeGroote Sr. in 1987 and is headquartered in Independence, OH.
Stock Forecast FAQ
In the current month, CBZ has received 1 Buy ratings 1 Hold ratings, and 0 Sell ratings. The CBZ average analyst price target in the past 3 months is $67.50.
-
Where Will CBIZ, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that CBIZ, Inc. share price will rise to $67.50 per share over the next 12 months.
-
What Do Analysts Say About CBIZ, Inc.?
Analysts are divided on their view about CBIZ, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CBIZ, Inc. is a Sell and believe this share price will drop from its current level to $60.00.
-
What Is CBIZ, Inc.'s Price Target?
The price target for CBIZ, Inc. over the next 1-year time period is forecast to be $67.50 according to 2 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is CBZ A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for CBIZ, Inc. is a Leans Bullish. 1 of 2 analysts rates the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of CBZ?
You can purchase shares of CBIZ, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CBIZ, Inc. shares.
-
What Is The CBIZ, Inc. Share Price Today?
CBIZ, Inc. was last trading at $31.22 per share. This represents the most recent stock quote for CBIZ, Inc.. Yesterday, CBIZ, Inc. closed at $33.98 per share.
-
How To Buy CBIZ, Inc. Stock Online?
In order to purchase CBIZ, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get CBZ Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CBZ
Sector
P/E ratio
22.37x
20.33x
PEG ratio
11.95x
0.18x
P/B ratio
0.99x
1.80x
Price / LTM sales
0.79x
0.89x
Growth Metrics
CBZ
Sector
Revenue growth
58.09%
4.57%
Earnings growth
-30.93%
3.54%
Revenue (5-year growth)
13.84%
4.49%
Earnings forecast
-$0.66
$0.33
Profitability
CBZ
Sector
Profitability FY 2024
$187.5M
$238.5M
Return on invested capital
3.13%
4.52%
Return on assets
2.55%
3.09%
Return on equity
6.21%
7.99%
Earnings Date
Last Earnings Date
Oct
29
Next Earnings Date
Feb
25
Estimated Next Earnings Date
Jan
28
Balance Sheet
CBZ
Sector
Total cash
$61.4M
$138.4M
Short term investments
--
$31.1M
Total assets
$4.7B
$1.4B
Long term debt
$1.9B
$44.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
48
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 29x
Alerts
Buy
73
NKTR alert for Feb 11
Nektar Therapeutics [NKTR] is up 16.63% over the past day.
Buy
53
ICHR alert for Feb 11
Ichor Holdings Ltd. [ICHR] is up 1.94% over the past day.
Sell
26
MEDP alert for Feb 11
Medpace Holdings, Inc. [MEDP] is down 4.66% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
